Home
About BCG
Contact Us
Locations
Services
Areas of Expertise
Regulatory Library
Newsletter Archive
Useful Web Links
Presentations
 

 

 

 


 

 




AREAS OF EXPERTISE
Experienced in the preparation of:
  • Summaries of Clinical Safety for New Drug Applications (NDAs)/Biologics License Applications (BLAs),
  • Clinical study reports,
  • Clinical study protocols,
  • Investigational New Drug (IND) Annual Reports,
  • Investigator brochures and
  • Informed consent documents
  • Proficient in the use of the International Conference on Harmonisation (ICH) Common Technical Document (CTD) format;
  • Trained Good Clinical Practice (GCP) auditor;
  • Provides safety data management services such as receiving, assessing, coding and preparing regulatory reports on emerging clinical trial safety data;
  • Trained user of the European Agency for the Evaluation of Medicinal Products (EMEA) EudraVigilance safety database and ArisGlobal

EDUCATION
ND   Doctor of Nursing, University of Colorado, Denver, CO (1999)
MSN   Master of Science in Nursing, Family Nurse Practitioner Program, University of Colorado, Denver, CO (2001)
BA   University of Maine, Portland, ME (1989)

EXPERIENCE:

CURRENT
POSITION:
Jan. 2005 - Present
 

Consultant, Biologics Consulting Group, Inc.
Boulder, CO.

  • Clinical consultant working with drugs and biologics in Phases I through III of development;
  • Medical writer with responsibility for analyzing and summarizing large, complex safety and efficacy data sets from clinical trials;
  • Evaluate and provide input on Statistical Analysis Plans (SAPs) for individual clinical studies and pooled clinical data sets;
  • Specialize in the preparation of Integrated Summary of Safety (ISS) and
  • Summary of Clinical Safety (SCS) documents for Biologics License Applications (BLAs) and New Drug Applications (NDAs);
  • Experienced in the preparation of clinical study protocols, clinical study reports, informed consent documents, IND Annual Reports, Investigator Brochures, IND
  • Safety Reports
  • Provide pharmacovigilance consulting services including serious adverse event processing plans, design and implementation of pharmacovigilance systems, and processing/reporting of SAEs
  • Provide auditing services including GCP and Pharmacovigilance systems audits
   
Jul 2002 - Dec. 2004  

Clinical Safety Associate II, OSI Pharmaceuticals, Boulder, CO.

  • Worked with six products in Phases I through III of development
  • Received, assessed, processed, and queried serious adverse event reports
  • Prepared and submited expedited reports, analyses of similar events and investigator letters
  • Assisted in data quality planning, CRF design, protocol review, informed consent preparation, and writing clinical study reports
  • Worked closely with Regulatory and Clinical Departments, development partners, CROs and regional medical monitors to ensure timely and accurate reporting of clinical trial safety data
  • Prepared periodic safety summaries, analyses, safety sections of IND Annual Reports and Investigator Brochures, and updated the development core safety information (DCSI) for these products
  • Performed database reconciliation, coding review and query generation
  • Authored departmental SOPs and guidelines
   
Jan. 2002 - Jan. 2004  

Clinical Safety Specialist/Consultant, Sirna Therapeutics/Ribozyme Pharmaceuticals, Boulder, CO.

  • Performed all clinical safety data management activities for company
  • Worked closely with Clinical, Biostatistics and Regulatory staff on protocol development, adverse event data collection planning, preparation of regulatory submissions, querying and data cleaning
  • Responsible for preparation of SAE form and instructions, safety section of IND Annual Reports, Investigator Brochures, ad hoc safety summaries and materials for Investigator meetings
  • Assisted in the identification of a safety signal and in notification of regulators and investigators
   
May 2001 - Jan. 2002  

Professional Research Associate, University of Colorado School of Medicine, Denver, CO.

  • Acted as a study coordinator for three ongoing clinical trials
  • Assessed, treated and managed pulmonary hypertension patients, including performing study-related assessments
  • Assisted in development of an investigator-sponsored protocol, designing the case report form, and creation of the study database
  • Submitted protocols and informed consent documents to the local Institutional Review Board
   
Jan. 2000 - May 2001  

Homeless Outreach Program, The People's Clinic, Boulder, CO.

  • Co-created and managed a new homeless outreach nursing program
  • Nurse case-managed medically fragile, homeless patients
  • Created and maintained a program utilization database
   
Sept. 1997 - Dec. 1999  

Clinical Instructor, Jan. 1999 to Dec. 1999, Doctoral Resident and Research Fellow, Sept. 1997 to Jan. 1999, University of Colorado School of Nursing, Denver, CO.

  • Completed an IRB-approved correlational study of 208 homeless women, regarding the relationship between their physical and mental health, substance abuse, family status and history of exposure to violence
  • Trained doctoral residents and nursing students
  • Assisted in creating a clinic and medical case management program
   
1995 - 2001  

Family Nurse Practitioner Program, 1999 to 2001, Nursing Doctorate Program, 1995 to 1999, University of Colorado Health Sciences Center, Denver, CO

  • Full-time graduate nursing student, completing over 3,000 hours of direct patient care and 1,000 hours of research during the period
  • National Health Service Corps Fellow, 1996

CONTINUING EDUCATION

2007 Interpreting and Reporting Biostatistics (Graham School, University of Chicago)
2006 Risk Management and Pharmacovigilance (DIA)
2005 GCP Auditing, Drug Information Association (DIA)
2004 Good Clinical Practice Training, CBR International
2004 EudraVigilance User Training, DIA/EMEA
2004 Principles of Molecular Oncology, ASCO
2003 Mt Sinai School of Medicine Chemotherapy Symposium
2003 DIA Annual Meeting, San Antonio, Texas
2002 Clinical Trial Drug Safety Assessment, PERI
2002 Clinical Drug Development 101, Drug Development Consulting
2002 MedDRA: An Introduction, Integrated Safety Systems

PROFESSIONAL ASSOCIATIONS
2004 - present   Member, American Medical Writers Association
2002 - present   Member, Drug Information Association

Page Updated: April 15, 2008